Nasal Drug Delivery Mode Market
- 2026 年市場規模
- USD 67.6 Bn
- 2033 年預估規模
- USD 100.3 Bn
- 年複合成長率 CAGR
- 5.8%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Nasal Drug Delivery Mode Market, By Therapeutic Application (Asthma, Rhinitis, and Others), By Dosage Form (Powder, Spray, and Gel), By Container Type (Pressurized Container, Non Pressurized, and Container), By System Type (Multi- Dose, Bi-Dose, and Unit Dose), By End Users (Hospitals and Homecare Settings), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
報告摘要
Drug delivery refers to the technology utilized to present the drug to the desired body site for drug release and absorption. Intranasal drug delivery offers a rapid onset of therapeutic effects (local or systemic). Nasal applications of topical decongestants or anti-inflammatory drugs are most popular topical nasal drug deliveries. Nasal delivery is the logical choice for treatment of diseases in the nose and paranasal sinuses. Over the years, nasal route has gained widespread interest as a promising and an alternative route to oral and parenteral drug delivery.
Market Dynamics
Growing prevalence of asthma and chronic obstructive pulmonary disease (COPD), increasing adoption of self-administration practices, and increasing preference for nasal drug delivery are some major factors expected to boost the growth of the global nasal drug delivery mode market over the forecast period. Asthma is a major noncommunicable disease (NCD) that affects both children and adults. For instance, according to the Asthma and Allergy Foundation of America (AAFA), more than 25 million people in the U.S. have asthma, about 1 in 13 people. Moreover, over 20 million adults aged 18 and older have asthma in the U.S., and asthma rates are highest in Black adults in the United States.
Key features of the study
• This report provides in-depth analysis of the global nasal drug delivery mode market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2026 to 2033), considering 2025 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the nasal drug delivery mode market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Merck & Co., Inc., Astra Zeneca, GlaxoSmithKline Plc, Mystic Pharmaceuticals, PendoPharm Inc., Bausch Health, 3M, Cadila Pharmaceuticals, Optinose, Dr. Reddy Laboratories, Neurelis Inc., Aptar Group, Johnson & Johnson Services Inc., ENT Technologies Pty Ltd., and Becton, Dickinson and Company, among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global nasal drug delivery mode market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global nasal drug delivery mode market.
Market Segmentation
• By Therapeutic Application (Revenue, USD Bn, 2021-2033)
o Asthma
o Rhinitis
o Others
• By Dosage Form (Revenue, USD Bn, 2021-2033)
o Powder
o Spray
o Gel
• By Container Type (Revenue, USD Bn, 2021-2033)
o Pressurized Container
o Non Pressurized
o Container
• By System Type (Revenue, USD Bn, 2021-2033)
o Multi- Dose
o Bi-Dose
o Unit Dose
• By End Users (Revenue, USD Bn, 2021-2033)
o Hospitals
o Homecare Settings
• By Distribution Channel (Revenue, USD Bn, 2021-2033)
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies
• By Region (Revenue, USD Bn, 2021-2033)
o North America
U.S.
Canada
o Latin America
Brazil
Mexico
Argentina
Rest of Latin America
o Europe
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC
Israel
Rest of Middle East
o Africa
South Africa
Central Africa
North Africa
• Key Players
o Merck & Co., Inc.
o AstraZeneca
o GlaxoSmithKline plc (GSK)
o Mystic Pharmaceuticals
o Johnson & Johnson Services Inc.
o PendoPharm Inc.
o Bausch Health Companies Inc.
o 3M Company
o Cadila Pharmaceuticals Ltd.
o OptiNose Inc.
o Reddy’s Laboratories Ltd.
o ENT Technologies Pty Ltd.
o Neurelis Inc.
o AptarGroup, Inc.
o Becton, Dickinson and Company
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Overview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snapshot, By Therapeutic Application
Market Snapshot, By Dosage Form
Market Snapshot, By Container Type
Market Snapshot, By System Type
Market Snapshot, By End Users
Market Snapshot, By Distribution Channel
Market Snapshot, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
o Impact Analysis
o Market Trends
o Key Developments
o Product Approval
o Collaboration/Merge/Acquisition
o Regulatory Landscape
o PEST Analysis
o Porter’s Five Forces Analysis
o Epidemiology
o Robust Pipeline Analysis
4. Global Nasal Drug Delivery Mode Market, By Therapeutic Application, 2021 – 2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022– 2033
Segment Trends
o Asthma
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
o Rhinitis
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
5. Global Nasal Drug Delivery Mode Market, By Dosage Form, 2021 – 2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 – 2033
Segment Trends
o Powder
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
o Spray
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
o Gel
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
6. Global Nasal Drug Delivery Mode Market, By Container Type, 2021 – 2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 – 2033
Segment Trends
o Pressurized Container
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
o Non Pressurized
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
o Container
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
7. Global Nasal Drug Delivery Mode Market, By System Type, 2021 – 2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 – 2033
Segment Trends
o Multi- Dose
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
o Bi-Dose
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
o Unit Dose
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
8. Global Nasal Drug Delivery Mode Market, By End Users, 2021 – 2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 – 2033
Segment Trends
o Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
o Homecare Settings
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
9. Global Nasal Drug Delivery Mode Market, By Distribution Channel, 2021 – 2033, (USD Bn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022 – 2033
Segment Trends
o Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
o Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
o Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
10. Global Nasal Drug Delivery Mode Market, By Region, 2021 – 2033, (USD Bn)
o Introduction
Market Share Analysis, By Region, 2026 and 2033 (%)
Y-o-Y Growth Analysis, For Regions, 2022–2033
Regional Trends
o North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By System Type, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
o U.S.
o Canada
o Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By System Type, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By System Type, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
o U.K.
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By System Type, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
o China
o India
o Japan
o ASEAN
o Australia
o South Korea
o Rest of Asia Pacific
o Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By System Type, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
o GCC
o Israel
o Rest of Middle East
o Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Therapeutic Application, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Container Type, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By System Type, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By End Users, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
o North Africa
o Central Africa
o South Africa
11. Competitive Landscape
o Heat Map Analysis
o Market Share Analysis
o Company Profile
Merck & Co., Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
AstraZeneca
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
GlaxoSmithKline plc (GSK)
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Mystic Pharmaceuticals
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Johnson & Johnson Services Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
PendoPharm Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Bausch Health Companies Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
3M Company
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Cadila Pharmaceuticals Ltd.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
OptiNose Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Dr. Reddy’s Laboratories Ltd.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
ENT Technologies Pty Ltd.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Neurelis Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
AptarGroup, Inc.
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
Becton, Dickinson and Company
o Company Highlights
o Product Portfolio
o Financial Performance
o Recent Highlights
o Market Strategies
o Analyst Views
12. Section
o References
o Research Methodology
o About Us
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們